Important Business Aspects of Immuno-Oncology: Issues and Controversies
PharmaTalkRadio20 Jun 2017

Important Business Aspects of Immuno-Oncology: Issues and Controversies

Originally recorded during a panel session at the 2017's Immuno-Oncology 360°, Mark Simon of Torreya Partners moderates the conversation around issues, controversies, and other important business aspects of IO. He's joined by IO360° lead advisor and SVP at GSK, Dr Axel Hoos, Dr Robert Ang of Neon Therapeutics, Dr Jeffrey Bockman from Defined Health, Dr Jeffrey Legos from Novartis Pharmaceuticals, and Dr Chandra Ramanathan at Bayer Healthcare. Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
liberal-halvtime
sinnsyn
forskningno
tomprat-med-gunnar-tjomlid
villmarksliv
kvinnehelsepodden
tidlose-historier
rss-paradigmepodden
rss-zahid-ali-hjelper-deg
rss-overskuddsliv
dekodet-2
rss-rekommandert
hva-er-greia-med
rss-inn-til-kjernen-med-sunniva-rose
abels-tarn
nevropodden